The vote on the equity incentive plan amendment is the most significant item, as increasing the share pool by 3% could lead to modest dilution. Traders should monitor the outcome of this vote and the company's future stock issuance activity.
Price Chart
Executive Summary
Tenaya Therapeutics is holding its annual shareholder meeting to elect three directors, ratify its auditor, and amend its equity incentive plan to increase shares by 3% and remove the 4 million share annual limit.
Key Financial Metrics
Key Facts
- Tenaya Therapeutics is holding its annual shareholder meeting on May 27, 2026.
- The meeting agenda includes electing three Class II directors: Amy Burroughs, Karah Parschauer, and Catherine Stehman-Breen.
- Shareholders will vote to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026.
- A proposal to amend and restate the 2021 Equity Incentive Plan to increase the number of shares reserved for issuance by approximately 3% of outstanding shares and remove the annual limit of 4 million shares.
Financial Impact
The proposed increase in shares reserved for issuance is approximately 3% of outstanding shares, but the exact dollar amount is not disclosed.
Risk Factors
- The increase in the equity incentive plan could lead to shareholder dilution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-158096 |
| Document: 0001193125-26-158096-index-headers.html | 0001193125-26-158096 |
| Document: 0001193125-26-158096-index.html | 0001193125-26-158096 |
| Document: 0001193125-26-158096.txt | 0001193125-26-158096 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | DEFA14A | $0.3945 | awaiting T+60 | — | $0.4151 (+5.22%) |
Oct 23, 2026 3d ago | DEF 14A | $0.3850 | awaiting T+60 | — | $0.4151 (−7.82%) |
Aug 17, 2026 10w ago | 144 | $0.6990 | awaiting T+60 | — | $0.4151 (+40.62%) |
Jul 2, 2026 16w ago | 8-K | $0.7869 $0.5898 | ▼ −25.05% | ▼ −28.62% | $0.4151 (−47.25%) |
Jun 29, 2026 17w ago | 8-K | $0.7349 $0.6822 | ▼ −7.17% | ▼ −11.56% | $0.4151 (−43.52%) |
Jun 12, 2026 19w ago | Institutional Cluster | $0.7118 $0.6634 | ▲ +6.80% | ▲ +10.06% | $0.4151 (+41.68%) |
May 29, 2026 21w ago | 8-K | $0.8700 $0.7014 | ▼ −19.38% | ▼ −20.61% | $0.4151 (−52.29%) |
May 19, 2026 22w ago | Insider Cluster | $0.8080 $0.7281 | ▼ −9.89% | ▼ −14.89% | $0.4151 (−48.63%) |
Apr 16, 2026 27w ago | DEFA14A | $0.7470 $0.8365 | ▲ +11.98% | ▲ +4.94% | $0.4151 (−44.43%) |
Mar 11, 2026 32w ago | 8-K | $0.8930 $0.7280 | ▼ −18.48% | ▼ −29.17% | $0.4151 (−53.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers